1853 related articles for article (PubMed ID: 18445828)
21. Review of the screening history of Alberta women with invasive cervical cancer.
Stuart GC; McGregor SE; Duggan MA; Nation JG
CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the effect of Papanicolaou screening in Sweden: record linkage between a central screening registry and the National Cancer Registry.
Pettersson F; Näslund I; Malker B
IARC Sci Publ; 1986; (76):91-105. PubMed ID: 3570419
[TBL] [Abstract][Full Text] [Related]
23. Papanicolaou smear screening interval and risk of cervical cancer.
Shy K; Chu J; Mandelson M; Greer B; Figge D
Obstet Gynecol; 1989 Dec; 74(6):838-43. PubMed ID: 2586947
[TBL] [Abstract][Full Text] [Related]
24. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
25. A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003.
Morrell S; Taylor R; Wain G
J Med Screen; 2005; 12(4):190-6. PubMed ID: 16417696
[TBL] [Abstract][Full Text] [Related]
26. Cytological screening history of patients with early invasive cervical cancer.
Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
[TBL] [Abstract][Full Text] [Related]
27. Screening history of women in Malmö with invasive cervical cancer.
Lindqvist PG; Hellsten C; Rippe A
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):77-83. PubMed ID: 17210219
[TBL] [Abstract][Full Text] [Related]
28. [Case-control study of the effectiveness of mass screening in reducing invasive cervical cancer].
Makino H; Sato S; Yajima A; Fukao A
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1226-32. PubMed ID: 1919184
[TBL] [Abstract][Full Text] [Related]
29. The Fitzroy Valley Pap Smear Register. Cervical screening in a population of Australian aboriginal women.
Mak DB; Straton JA
Med J Aust; 1993 Feb; 158(3):163-6. PubMed ID: 8450781
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer screening. Past success and future challenge.
Dewar MA; Hall K; Perchalski J
Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
[TBL] [Abstract][Full Text] [Related]
31. Alcoholism and risk for cancer of the cervix uteri, vagina, and vulva.
Weiderpass E; Ye W; Tamimi R; Trichopolous D; Nyren O; Vainio H; Adami HO
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):899-901. PubMed ID: 11489758
[TBL] [Abstract][Full Text] [Related]
32. Trends in abnormal cancer screening results in the United States of America.
Yabroff KR; Freedman A; Brown ML; Ballard-Barbash R; McNeel T; Taplin S
J Med Screen; 2007; 14(2):67-72. PubMed ID: 17626704
[TBL] [Abstract][Full Text] [Related]
33. Breast and cervical cancer screening among Appalachian women.
Hall HI; Uhler RJ; Coughlin SS; Miller DS
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):137-42. PubMed ID: 11815412
[TBL] [Abstract][Full Text] [Related]
34. [Organized cervical cancer screening for underpriviledged women].
Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
[TBL] [Abstract][Full Text] [Related]
35. Screening differences and risk of cervical cancer in inflammatory bowel disease.
Hutfless S; Fireman B; Kane S; Herrinton LJ
Aliment Pharmacol Ther; 2008 Sep; 28(5):598-605. PubMed ID: 18549465
[TBL] [Abstract][Full Text] [Related]
36. Pap smear screening in a health maintenance organization: 1986-1990.
Rolnick S; LaFerla JJ; Wehrle D; Trygstad E; Okagaki T
Prev Med; 1996; 25(2):156-61. PubMed ID: 8860280
[TBL] [Abstract][Full Text] [Related]
37. Cervical cancer screening programs: summary of the 1982. Canadian task force report.
Can Med Assoc J; 1982 Oct; 127(7):581-9. PubMed ID: 7127225
[TBL] [Abstract][Full Text] [Related]
38. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.
Pak SC; Martens M; Bekkers R; Crandon AJ; Land R; Nicklin JL; Perrin LC; Obermair A
Aust N Z J Obstet Gynaecol; 2007 Dec; 47(6):504-7. PubMed ID: 17991118
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
Smrkolj S; Rakar S; Mozina A; Erzen M
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
[TBL] [Abstract][Full Text] [Related]
40. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
